TOP2A and breast carcinoma: For example, inhibition of DNA topoisomerase II alpha by doxorubicin may interrupt the efficient repair of DNA damage caused by cisplatin in EMT6 mouse mammary carcinoma or human glioblastoma cells [56,57].